Product Information
DEXTROAMP-AMPHET ER 15 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.5105 per EA under NDC 00527551237. Its NADAC has been published 267 times since Oct 21, 2020.
The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHET ER 15 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527551237
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has been published 267 times since Oct 21, 2020, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5105 per EA |
|---|---|
| All-time high | $1.0330 (Nov 11, 2020) |
| All-time low | $0.4362 (May 22, 2024) |
| 52-week high | $0.6140 |
| 52-week low | $0.5015 |
| Median price | $0.6084 |
| Average price | $0.6305 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 267 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 15 MG CAP, manufactured by Lannett Company Inc., is $0.5105 per EA (NDC 00527551237), effective Nov 26, 2025.
How has the price of DEXTROAMP-AMPHET ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has declined 50.6%. It has been tracked across 267 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 15 MG CAP?
Since Oct 21, 2020, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has ranged from a low of $0.4362 (May 22, 2024) to a high of $1.0330 (Nov 11, 2020), with a median of $0.6084 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 15 MG CAP?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHETAMIN 15 MG TAB, is $0.2423 per EA — about 53% below DEXTROAMP-AMPHET ER 15 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 15 MG CAP?
DEXTROAMP-AMPHET ER 15 MG CAP (NDC 00527551237) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification